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ABSTRACT: Cellular genomes are vulnerable to an array of DNA-damaging agents, of both
endogenous and environmental origin. Such damage occurs at a frequency too high to be
compatible with life. As a result cell death and tissue degeneration, aging and cancer are
caused. To avoid this and in order for the genome to be reproduced, these damages must be
corrected efficiently by DNA repair mechanisms. Eukaryotic cells have multiple mechanisms
for the repair of damaged DNA. These repair systems in humans protect the genome by
repairing modified bases, DNA adducts, crosslinks and double-strand breaks. The lesions in
DNA are eliminated by mechanisms such as direct reversal, base excision and nucleotide
excision. The base excision repair eliminates single damaged-base residues by the action of
specialized DNA glycosylases and AP endonucleases. Nucleotide excision repair excises
damage within oligomers that are 25 to 32 nucleotides long. This repair utilizes many proteins
to remove the major UV-induced photoproducts from DNA, as well as other types of modified
nucleotides. Different DNA polymerases and ligases are utilized to complete the separate
pathways. The double-strand breaks in DNA are repaired by mechanisms that involve DNA
protein kinase and recombination proteins. The defect in one of the repair protein results in
three rare recessive syndromes: xeroderma pigmentosum, Cockayne syndrome, and
trichothiodystrophy. This review describes the biochemistry of various repair processes and
summarizes the clinical features and molecular mechanisms underlying these disorders.
KEY WORDS: DNA damage, UV photoproducts, excision repair, double-strand break
repair, DNA repair disorders.
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I. INTRODUCTION
It is of vital importance for all living
systems to ensure proper functioning and
propagation of their genetic information.
Numerous structural lesions or disorders
accumulate in DNA either spontaneously or
following genotoxic stress and as a result of
this a severe threat to the stability of DNA
is posed. The various chemical and physical
genotoxic agents damage DNA and thereby
induce mutations. These DNA lesions ham-
per processes like replication and transcrip-
tion at the cellular level and this result in
cell-cycle arrest, genomic instability and cell
death. Both exogenous and endogenous
agents cause the damage to DNA. Some of
the exogenous DNA mutating agents are
ultraviolet radiation, ionizing radiation, and
alkylating agents. Ultraviolet irradiation and
alkylating agents can cause a number of
specific base changes, as well as cross-link-
ing bases together. Ionizing radiation is
thought to generate the majority of its mu-
tational load by free radical production. On
the other hand, the endogenous mutagen-
esis is the inevitable consequence of a large
complex molecule present in a metaboli-
cally active environment. Some of the ex-
amples are depurination (which occurs be-
cause of the reaction of DNA in water), the
effect of oxygen and free radicals (causing
base damage and DNA strand breaks), and
the errors caused by DNA replication (caus-
ing base mismatches and deletions).
The DNA double helix seems to have
evolved so that mutations, even as small as
individual base damage are easily recog-
nized. Such recognition is usually by a
change in the physical structure of the DNA
double helix. Living cells have developed
various strategies to eliminate most of these
lesions so as to preserve a life-compatible
genetic information and to do this efficiently
an intricate network of DNA repair system
has been generated. The repair systems pro-
tect the genome by repairing modified bases,
DNA adducts, and crosslinks and double-
strand breaks. Eukaryotic cells have mul-
tiple mechanisms for repairing damaged
DNA. Furthermore, these pathways are co-
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ordinated with other cellular functions, in
particular gene transcription and cell cycle.
The three basic mechanisms by which
lesions are eliminated from DNA are
1. Direct reversal (DR), carried out by
O6-methylguanine-DNA methyltrans-
ferase, which directly reverses some
simple alkylation adducts.
2. Base excision repair (BER), which
eliminates single damaged-base resi-
dues.
3. Nucleotide excision repair (NER),
which excises damage within oligo-
mers that are about 25 to 29 nucle-
otides long. This type of repair removes
primarily bulky, helix distorting ad-
ducts. However, considerable overlap
exists in substrate specificity of repair
pathways and certain proteins are used
in more than one pathway (Lindahl et
al., 1997).
BER pathway is an essential pathway
for DNA maintenance. It works mainly on
nonbulky base adducts such as those caused
by hydrolysis, oxygen free radicals and
simple alkylating agents. The most obvious
function of NER in eukaryotes is to remove
the major UV-induced photoproducts caused
by sunlight from irradiated DNA or it can
repair the DNA containing bulky adducts.
In particular the NER system repairs virtu-
ally everything and requires the action of
multiple interacting proteins that locate the
damage in DNA, remove it as a short oligo-
nucleotide and synthesize a replacement
patch.
UV radiation produces damage to DNA
and induces formation of two major UV
photoproducts, the cyclobutane pyrimidine
dimers and 6-4 photoproducts (Figure 1).
The cyclobutane pyrimidine dimers can be
formed between any two adjacent pyrim-
idines. In Figure 1A, a thymine-thymine
cyclobutane pyrimidine dimer is shown
which is the most frequently occuring UV
photoproduct (Protic-Sabljic et al., 1986;
Doetsch, 1995). The 6-4 photoproducts are
formed by covalent bond between the car-
bon 6 and carbon 4 of adjacent pyrimidines.
These are the most frequently occurring UV
photoproducts and occur at 5′-T-C-3′ (Fig-
ure 1 B), 5′-C-C-3′ and 5′-T-T-3′, but not at
5′-C-T-3′ sites in DNA (Doetsch, 1995).
Both of these photoproducts are toxic and
mutagenic lesions, which can be repaired
by a number of pathways. These repair path-
ways include DNA excision repair (com-
prising the BER and NER pathways), enzy-
matic photoreactivation, recombination
repair and post replications repair (Friedberg
et al., 1995).
In animal cells, the major lesions caused
by 254-nm UV light, cyclobutane pyrimi-
dine dimers, are removed from the bulk of
the genome 5 to 10 times more slowly than
the second most abundant lesions, 6–4 pho-
toproducts (Mitchell and Nairn, 1989;
Szymkowski et al., 1993b). In UV-irradi-
ated primates a DNA-binding protein spe-
cific for 6–4 photoproducts has been de-
tected, suggesting that in mammalian cells
different pathways may be used for the re-
pair of these two photoproducts (Pfeifer et
al., 1991).
Apart from chemical alterations to the
bases in DNA, an important type of damage
produced in DNA is the double-strand
breaks. These are made under physiological
conditions during somatic recombination and
transposition. They are also one of the ma-
jor products of ionizing radiation and of
oxidative stress. There are at least two ways
of repairing double-strand breaks in eukary-
otes. The first, which mainly takes place in
yeast, involves homologous recombination
with a sister duplex. The second pathway
which, predominates in mammals is an end-
joining process, which employs the DNA-
dependent protein kinase.
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II. DIRECT REVERSAL
DR is the simplest mechanism, which
involves a single enzyme reaction for re-
moval of certain types of DNA damage.
Alkyltransferases simply extract the alkyl
group from alkylated bases that is trans-
ferred to an internal cysteine residue, and
thus inactivating themselves (Teo et al.,
1984). The best example for DR is the cor-
rection of the miscoding alkylation lesions
O6–methylguanine, which are generated
endogenously in small amounts by reactive
cellular catabolites. DR is carried out by a
specific enzyme called methylguanine-
methyltransferase (MGMT), which removes
the methyl group from the guanine residue
of DNA, and transfers it to one of its own
cysteine residues in a rapid and error free
repair process (Moore et al., 1998). O6–
methylguanine can pair with both C and T
and thereby causes transition mutations,
which are sometime corrected by, mismatch
repair mechanism (O’Driscoll et al., 1998;
Lindahl and Wood, 1999). Photolyases, on
the other hand, revert UV-induced dimers
in a light dependent reaction called photo-
reactivation (Sancar, 1990; Yasui and Eker
1998; Todo, 1999).
FIGURE 1. UV-light-induced DNA photoproducts. (A) Cyclobutane pyrimidine dimers (T-T). (B)
6-4 Photoproducts (5′-T-C-3′).
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III. BASE EXCISION REPAIR
BER works mainly on DNA damages
that can arise spontaneously in a cell from
hydrolytic events such as deamination or
base loss, fragmented bases resulting from
ionizing radiation and oxidative damage or
methylation of ring nitrogens by endogenous
agents. BER pathway is the most important
cellular protection mechanism responding
to oxidative DNA damage, whether it oc-
curs from reactive oxygen species formed
during normal metabolism or from expo-
sure to exogenous agents. A model for BER
pathway is shown in Figure 2. There are
two key events in base excision repair. First
is the hydrolysis of the N-glycosyl bond
linking a modified (or damaged) base to the
deoxyribose-phosphate chain, which excises
the base residue in the free form and creates
an AP (apurinic/apyrimidinic) site on sugar-
phosphate backbone of DNA. The class of
enzymes called glycosylases carries out this
release. Different DNA glycosylases remove
different kinds of damage, and the specific-
ity of repair pathway is determined by the
type of glycosylase involved (Seeberg et
al., 1995). In the second event of the reac-
tion the resulting abasic sugar is cleaved by
an AP endonuclease at 5′ to the AP site.
There are a number of well-characterized
glycosylases but only one major endonu-
clease has been reported in humans so far
(Wood, 1996). This type of repair has a
limited substrate range since the DNA
glycosylases that initiate the repair process
are in intimate contact with the lesion dur-
ing catalysis. Completion of base excision
repair requires the removal of the 5′ termi-
nal deoxyribose-phosphate residue gener-
ated by the endonuclease, which is cata-
lyzed by the phosphodiesterase activity of
DNA polymerase β. The resulting one-nucle-
otide gap is filled by DNA polymerase β
and sealed by either DNA ligase I or DNA
ligase III with its accessory protein XRCC1
(Figure 2) (Lehmann, 1998). One of the
several available alternate pathways can
often repair a given lesion because com-
plete loss of base excision repair would be
incompatible with life.
A double knockout mutation of poly-
merase β in mice causes embryonic lethal-
ity (Gu et al., 1994). This finding suggests
that either the single-patch mode of BER is
essential for maintaining normal viability or
that polymerase β has an additional essen-
tial role in mammalian cells such as in chro-
mosomal DNA replication.
IV. NUCLEOTIDE EXCISION
REPAIR
The main function of the ubiquitous
nucleotide excision repair pathway is the
removal of UV-induced lesions from DNA.
It is the process whereby DNA damage is
removed as part of an oligonucleotide frag-
ment, followed by replacement with new
DNA using the intact strand as template.
This type of repair requires the action of
multiple interacting proteins that locate the
damage in DNA, remove it as a short oligo-
nucleotide and synthesize a replacement
patch. This process occurs in stepwise fash-
ion, beginning with recognition of the DNA
lesion, followed by enzymatic incisions in
the damaged strand on both sides of the
lesion, removal of the damaged single-
stranded segment, repair synthesis to fill in
the resultant gapped DNA duplex and liga-
tion of the repair patch to the existing DNA
strand. Six core factors, comprising 15 to 18
polypeptides, are required for dual incision
of damage and another dozen or so polypep-
tides are needed for the repair synthesis
step. The nucleotide excision repair machin-
ery has very broad substrate specificity,
being able to recognize a wide variety of
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FIGURE 2. A model for base excision repair pathway in
mammalian cells. AP endonuclease = apurinic/apyrimidinic
endonuclease. PDE = phosphodiesterase.
Cr
iti
ca
l R
ev
ie
w
s i
n 
Bi
oc
he
m
ist
ry
 a
nd
 M
ol
ec
ul
ar
 B
io
lo
gy
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
11
7.
21
5.
12
9.
17
3 
on
 0
8/
01
/1
1
Fo
r p
er
so
na
l u
se
 o
nl
y.
267
chemical alterations to DNA that result in
large local distortions of the DNA structure.
A. Steps and Proteins Involved
in Nucleotide Excision Repair
The molecular mechanism of NER
pathway in human is shown in Figure 3.
This process involves the products of at
least 30 genes. A defect in any of these
genes leads to defective NER and results
in a series of genetic disorders, which are
discussed later.
Most of the mammalian NER genes have
been isolated by transfection of genomic
DNA into UV-sensitive rodent repair mu-
tants followed by selection of UV-resistant
transformants and retrieval of the correcting
sequence (Hoeijmakers, 1993). The human
genes correcting rodent repair defects are
called ERCC genes, for excision repair cross-
complementing rodent repair deficiency
genes. The number refers to the rodent group
that has been corrected.
Although most of the important players
in mammalian NER are identified but only
very recently have we begun to gain some
insight into the mechanism by which pro-
teins recognize chemical and structural
modifications of canonical DNA, resulting
from damage (Pearl and Savva, 1995;
Lowndes and Murguia, 2000). Recently a
“bipartite” or two-step model for recogni-
tion has been proposed (Lindahl and Wood,
1999). In the first step, a distortion is recog-
nized and in the second, the damaged strand
and chemical alterations are located.
It has been established that binding of
the XP-C is the initial, damage-recognizing
step in NER, which recruits the entire repair
protein apparatus to the damage (Sugasawa
et al., 1998). XP-E also has a role in damage
recognition of cyclobutane pyrimidine le-
sions because it has a high affinity for UV-
damaged DNA (Keeney et al., 1993). XP-A
protein may be important for verification of
the damage and for proper organization of
the repair apparatus around the lesion since
it has a high affinity for DNA, with a pref-
erence for UV-damaged DNA (Tanaka et
al., 1989; Robins et al., 1991; Eker et al.,
1992; Jones and Wood, 1993). The protein
has been cloned and studied in detail (Tanaka
et al., 1990). XP-A protein is a core factor
in the NER complex, showing key interac-
tions with RPA, ERCC1 and TFIIH (Figure
3). Apart from its ability to bind to damaged
DNA via a zinc-finger domain, different
parts of it interact with other NER proteins.
One domain can bind to the single-strand-
binding protein RPA, and this association
increases the binding affinity of XP-A for
damaged DNA (He et al., 1995). Another
part of the XP-A protein can bind to the
basal transcription factor TFIIH, which was
shown to have a role in NER as well as in
basal transcription (Park et al., 1995;
Lehmann, 1998). Several DNA-unwinding
enzymes termed helicases participate in le-
sion recognition and in removal of the dam-
aged segment. XP-B (ERCC3) and XP-D
(ERCC2) both contain the seven conserved
domains of the superfamily of DNA and
RNA helicases (Weber et al., 1990; Weeda
et al., 1990; Gorbalenya and Koonin, 1993).
In addition both proteins have been shown
to possess DNA unwinding activity, but of
opposite polarity (Sung et al., 1993; Roy et
al., 1994). XP-B and XP-D and other pro-
teins like p62, p44, p34, and p52 (Figure 3)
are the subunits of TFIIH (Schaeffer et al.,
1993; Schaeffer et al., 1994; Lehmann,
1998). The function of these helicases is to
open up the structure around the damaged
site to enable the structure-specific nucleases
to incise the DNA and full opening of the
DNA helix around the lesion is dependent
on the presence of ATP (Evans et al., 1997).
Mice with inactivating mutations in the
TFIIH subunits XP-B and XP-D are invi-
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FIGURE 3. A model for nucleotide excision repair in mamma-
lian cells. The figure shows from top to bottom damage recog-
nition, unwinding of a region around the lesion, dual incision,
repair synthesis, and ligation of the newly synthesized patch.
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able which suggests an essential role of these
components in basal transcription (de Boer
et al., 1998b).
An oligonucleotide of about 30 nucle-
otides is excised after local unwinding and
demarcation of the lesion. The incision pat-
tern and size of the excised fragment are
highly variable. Two incisions (5′ nick and
3′ nick) are introduced into the damaged
DNA strand, one on each side of a DNA
lesion (Figure 3). A multisubunit ATP-de-
pendent nuclease known as excision nu-
clease or excinuclease makes the dual inci-
sions, one on either side of the lesion and
excises the oligonucleotide carrying the
damaged portion. For psoralen monoadducts
and cyclobutane pyrimidine dimers, one in-
cision is made 5 to 6 phosphodiester bonds
3′ to the lesion, and another incision 22 to
24 phosphodiester bonds away from the le-
sion on the 5′ side, resulting in excision
fragments 27 to 32 nucleotides long
(Svoboda et al., 1993). The dual incision is
absolutely dependent on ATP hydrolysis
(Svoboda et al., 1993). Two different nu-
cleases are used to create the dual incisions.
ERCC1-XPF and XP-G are both structure-
specific nucleases with different specificity’s
(O’Donovan et al., 1994a; O’Donovan et
al., 1994b). Both can cleave Y-type struc-
tures at the junction of the single and double-
stranded regions. XP-G cuts structure spe-
cifically, 3′ of a single-stranded bubble
region in duplex DNA (O’Donovan et al.,
1994a). ERCC1/XP-F cuts on the strand
that leads off from the junction in the 5′ to
3′ direction (Scherly et al., 1993; Bardwell
et al., 1994; Sijbers et al., 1996).
The specificity of ERCC1/XP-F seems
to be coordinated by RPA, which binds with
defined polarity to the undamaged strand.
Its 3′-oriented side stimulates ERCC1/XP-
F whereas the 5′-oriented side inhibits en-
donuclease activity of ERCC1/XP-F, in the
undamaged strand (de Laat et al., 1998).
The specificities of these two nucleases make
them ideally suited to cleave the opened up
damaged site on either side of the damage.
The result is the removal of a piece of DNA
about 25 to 30 nucleotides in length (Figure
3). The size of the repair patch formed dur-
ing nucleotide excision repair is about 25 to
30 nucleotides long as determined by in
vivo (Th’ng et al., 1986; Cleaver et al., 1991)
and in vitro studies (Hansson et al., 1989;
Huang et al., 1992; Shivji et al., 1992;
Szymkowski et al., 1993a). Disruption of
the ERCC1 subunit of the ERCC1-XP-F
nuclease has severe consequences. Animals
with this disorder are abnormally small, die
before weaning, and show chromosome and
tissue abnormalities in the liver and other
organs (McWhir et al., 1993; Weeda et al.,
1997a). Knockouts of XP-G in mice and
humans are also very severe. Such mice die
early because of failure to properly develop
the intestine (Harada et al., 1999).
The human single-stranded DNA bind-
ing protein replication protein A (RPA) plays
important role in NER. A speculative role
for RPA in this type of repair is the stabili-
zation of the single-stranded nature of DNA
around a lesion, generated by the coopera-
tive action of damage recognition proteins
and helicases. One single RPA unit protects
a region of nearly 30 nucleotides and
matches well with the size of an excision
repair patch, supporting the suggested role
of RPA in NER (Kim et al., 1992; Shivji et
al., 1995). XP-G and RPA interact directly,
but RPA alone is not sufficient to endow
strand specificity on XP-G. The strong in-
teraction between TFIIH and XP-G suggest
that TFIIH is required for proper position-
ing of XP-G (Iyer et al., 1996).
The last step in the NER mechanism,
gap-filling of the excised patch, is least spe-
cific and this DNA repair synthesis is per-
formed by common DNA replication fac-
tors. An in vitro reconstituted repair reaction
showed that efficient repair synthesis re-
quires the mammalian replication factors
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RPA, replication factor C (RF-C), prolifer-
ating cell nuclear antigen (PCNA), and
DNA polymerase δ and ε (Hubscher and
Thommes, 1992; Shivji et al., 1995). It was
proposed that repair synthesis requires poly-
merase δ and polymerase α (Dresler and
Frattini, 1986; Nishida et al., 1988; Keeney
and Linn, 1990; Syvaoja et al., 1990; Hunt-
ing et al., 1991; Coverley et al., 1992;
Popanda and Thielmann, 1992; Aboussekhra
et al., 1995; Lehmann, 1995; Lehmann,
1998). This role was further strengthened
by the finding that PCNA is required for
NER by mammalian cell extracts (Nicholas
and Sancar, 1992; Shivji et al., 1992) as
only polymerase δ and polymerase α re-
quire PCNA (Kelman, 1997). It has been
shown that PCNA functions in NER syn-
thesis and in filling of short single-stranded
gaps by assisting in the initiation of DNA
synthesis (Podust et al., 1994; Shivji et al.,
1995). In repair synthesis PCNA may serve
as an anchoring clamp at the 3′-OH termi-
nus of a DNA strand to which polymerase
can bind (Nicholas and Sancar, 1992; Shivji
et al., 1992).
The participation of PCNA in NER sug-
gests that another DNA polymerase acces-
sory factor, RFC, be also involved. The
multisubunit RFC factor acts as a molecular
matchmaker for PCNA (O’Donnel et al.,
1993; Sancar and Hearst, 1993). RFC assists
PCNA to load onto gapped DNA templates
in an ATP-dependent manner, creating a slid-
ing clamp for polymerase δ and polymerase
α (Hubscher and Spadari, 1994; Kelman and
O’Donnell, 1994; Podust et al., 1994;
Cullmann et al., 1995). The gap is filled in a
precise manner without enlargement in ei-
ther direction, the 3′ or 5′ and hence the
repair patch exactly matches the excision
patch (Figure 3) (Huang et al., 1992).
Finally, sealing (ligation) of the newly
synthesized DNA to the existing DNA com-
pletes the NER process. The repair patch is
then sealed by any of the four distinct ATP-
dependent DNA ligases, most likely ligase
I (Figure 3) (Lindahl and Barnes, 1992;
Petrini et al., 1995) because mutations in
the gene for DNA ligase I can give rise to a
UV-sensitive phenotype (Barnes et al.,
1992). To ensure the removal of damaged
sites without disruption to the rest of the
genome it is very necessary that the events
be carried out in the correct order.
A plant homologue of human ERCC1 gene
has been reported from male germline cells of
lily (Xu et al., 1998). The protein encoded by
the plant gene is also reported to correct signifi-
cantly the sensitivity to the cross-linking agent
mitomycin C in ERCC1-deficient Chinese ham-
ster ovary cells (Xu et al., 1998). These results
suggest that the NER mechanism is conserved
in yeast, animals, and higher plants.
V. DNA DOUBLE-STRAND
BREAK REPAIR
DNA double-strand breaks are created
by ionizing radiation (Dizdaroglu, 1992),
chemical agents and can also occur as inter-
mediates in certain somatic recombination
such as V(D)J recombination, and perhaps
during transposition reactions (Lieber,
1991). V(D)J recombination is the genomic
rearrangement that creates antigen-receptor
diversity in vertebrates (van Gent et al.,
1995). Failure to rejoin breaks can lead to
loss of portions of chromosomes or to rear-
rangements. If genes inactivated by such
events encode essential cellular components,
then cell death will occur.
A. Proteins Involved in DNA
Double-Strand Break Repair
The DNA-dependent protein kinase
(DNA-PK) is  required for  normal
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double-strand break rejoining activity in
mammalian cells. It is a heterotrimer
consisting of a p450 catalytic subunit
and Ku86 and Ku70 regulatory subunits
(Anderson, 1993; Tuteja et al., 1994;
Tuteja and Tuteja, 2000). This DNA-PK
holoenzyme is activated after binding to
DNA strand breaks and is able to phos-
phorylate many protein substrates in
vitro, although its physiological targets
are unclear (Anderson, 1994; Hartley et
al., 1995). Mammalian cells that are
deficient in catalytic subunit of DNA-
PK or Ku protein show highly charac-
teristic defects. The most noticeable of
these is sensitivity to ionizing radiation
that induces double-strand DNA breaks
(Rathmell and Chu, 1994; Taccioli et
al., 1994; Boubnov et al., 1995). In ad-
dition to having a defect in general
double-strand break rejoining, mutants
with defects in components of DNA-PK
are also unable to perform correct re-
combinational V(D)J rejoining of ma-
turing immunoglobulin genes (Blunt et
al., 1995). The end-binding activity of
Ku may serve as an entry site for other
proteins and the phosphorylation activ-
ity of DNA-PK may activate or inhibit
other repair factors (Tuteja and Tuteja,
2000). The repair of double-strand
breaks by homologous recombination
with another allele can be achieved with
high f idel i ty ,  whereas  repair  by
nonhomologous end joining may result
in lost or changed genetic information.
The balance between these two path-
ways is apparently influenced by the
relative amounts of RAD52 and Ku (Van
Dyck et al., 1999).
Recently nibrin, a novel DNA double-
strand break repair protein, has been identi-
fied and it has been shown that it is directly
involved in the processing of DNA double-
strand breaks caused by ionizing radiation
(Varon et al., 1998; Digweed et al., 1999).
VI. DISORDERS OF DNA REPAIR
Three rare, autosomal recessive disor-
ders are known to be based on NER defi-
ciency; the prototype NER disease, xero-
derma pigmentosum (XP) (Cleaver, 1968),
Cockayne’s Syndrome (CS) (Nance and
Berry, 1992) and photosensitive form of
trichothiodystrophy (TTD) (Itin and
Pittelkow, 1990; Stefanini et al., 1993a;
Stefanini et al., 1993b). These diseases
show distinct clinical phenotypes. The
hallmarks of XP are sun sensitivity, pig-
mentation changes, and an increased inci-
dence of skin cancer (Kraemer et al.,
1987). CS exhibits growth and mental
retardation and a characteristic bird-like
face as well as neurodegeneration and
retinal degeneration (Nance and Berry,
1992). TTD is characterized by sulfur-
deficient brittle hair together with growth
and mental retardation (Itin and Pittelkow,
1990). Neither CS nor TTD is cancer prone
(Lehmann, 1995).
Ataxia Telangiectasia (AT) is an auto-
somal recessive disorder characterized by
cerebellar ataxia, high incidence of cancers
and hypersensitivity to ionizing radiation
but not to UV (Swift et al., 1991). In addi-
tion, there are immune deficiencies, both
cellular and humoral, and a greatly elevated
incidence of tumors, especially of the
lymphoreticular system. Increased chromo-
some breakage is observed in cultured lym-
phocytes and fibroblasts from AT patients,
adding AT to the list of ‘chromosome break-
age’ or ‘chromosome instability’ syndromes
(Shiloh, 1997; Lehmann and Carr, 1995).
Nijmegen breakage syndrome (NBS) is
also an autosomal recessive ‘chromosomal
instability’ syndrome characterized by mi-
crocephaly, growth retardation, immunode-
ficiency and cancer predisposition. Cells from
NBS patients are hypersensitive to ionizing
radiation with cytogenetic features indistin-
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guishable from ataxia telangiectasia (Digweed
et al., 1999). The immunologic characteris-
tics of NBS encompass both developmental
defects in tissues where lymphocytes develop
and cellular defects in the responses of these
cells to stimuli (Chrzanowska et al., 1995).
The focus of the present review is to
describe the photosensitive syndromes: xe-
roderma pigmentosum, Cockayne’s syn-
drome, and trichothiodystrophy in greater
detail in the following sections.
A. Xeroderma Pigmentosum
Xeroderma pigmentosum (XP) is an ex-
tremely rare, autosomal recessive disease.
The skin of the patients is normal at birth
but develops progressive atrophy, irregular
pigmentation and later basal cell and squa-
mous cell carcinomas. The sun exposure of
XP patients generally results in progressive
degenerative alterations of the skin and eyes
and the mean age of onset of these symp-
toms is about two years (Kraemer, 1997).
The disease is characterized by extreme
sensitivity to sun exposure, a high incidence
of skin cancer and frequent neurological
abnormalities. This disease involves DNA
repair and replication deficiencies that pre-
dispose homozygous individuals to a 1000-
fold increase in non melanoma and mela-
noma skin cancers. Two major forms of XP
are known: one form is caused by a defect
in excision repair and the other lacks the
capacity to replicate damaged DNA. The
diagnostic features of XP are dry scaly skin
(xeroderma), abnormal pigmentation on sun-
exposed areas of the skin (pigmentosum)
photosensitivity and marked predisposition
to skin cancer (Cleaver and Kraemer, 1994;
Woods, 1998). XP patients are extremely
sensitive to solar exposure due to the DNA
damaging effect of the UV component of
sunlight (Cleaver and Kraemer, 1994). It is
characterized by photodermatoses includ-
ing skin cancer at an early age, and in some
cases neurological abnormalities (Robbins
et al., 1974; Chu and Mayne, 1996). A large
group of XP patients exhibit a high risk
toward the development of cutaneous ma-
lignancies (basal cell carcinomas, squamous
cell carcinomas, and melanomas).
Up to 50% of XP patients have associ-
ated symptoms of the De Sanctis-Cacchione
syndrome (DSC), which includes immature
sexual development, growth retardation and
neurological abnormalities of mental retar-
dation, microcephaly and sensorineural deaf-
ness (DeSanctis and Cacchione, 1932). DSC
describes mainly neurologic and develop-
mental abnormalities of individuals with a
freckling (pigmentosum) and parchment (xe-
roderma)-like skin. It was later discovered
that all DSC patients belong to XP, and the
DSC designation has gone out of use.
A fraction of XP patients display pro-
gressive neurological abnormalities. The
neurological abnormalities correlate with
postmortem findings of premature neuronal
death in the central and peripheral nervous
systems. The (progressive) neurological
symptoms in XP are intellectual deteriora-
tion, loss of the ability to talk and increasing
spasticity, which are all thought to be due to
primary neuronal degeneration (Robbins et
al., 1991).
XP cells are hypersensitive to ultravio-
let (UV) radiation owing to a defect in the
NER pathway. DNA repair synthesis after
UV-irradiation, as measured by tritiated thy-
midine incorporation (autoradiographically)
is severely reduced in XP (Cleaver, 1968).
A series of mutagenesis studies on these
cells revealed that XP cells are hypermut-
able after UV challenge. The spectrum of
UV-induced mutations in XP cells is also
different from that in NER-proficient cells.
XP patients are clinically very hetero-
geneous. Consequently, heterogeneity in
severity of the repair defect and of symp-
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toms such as sun sensitivity and neuronal
abnormalities is found. The symptoms vary
from severe neurological implications and a
high number of skin tumors to mild pig-
mentary abnormalities without signs of neu-
rological abnormalities. This variation can
be due to differences in genetic background
of affected persons or to allelic variation. It
has been shown by cell fusion studies that
XP is a multigenic disorder (De Weerd-
Kastelein et al., 1972). Cell fusion experi-
ments based on complementation of repair
synthesis have recognized the presence of
seven XP groups which exhibit various de-
fects in the initial steps of the DNA NER
pathway (XP-A through XP-G, each carry-
ing a mutation in a different gene) that are
characterized by varying levels of UV sen-
sitivity and corresponding deficiencies in
repair (Vermeulen et al., 1991; Hoeijmakers,
1993; Cleaver, 2000). With the exception of
XP-E, all the XP proteins appear to be ab-
solutely required for nucleotide excision
repair using the in vitro assay. It has been
shown using in vivo assay that XP-A cells
have minimal repair activity, because XP-A
is involved in the recognition step of NER
(Cleaver and States, 1997). XP-E cells have
substantial repair activity, consistent with
the partial requirement of XP-E protein in
NER. Cells in several other complementa-
tion groups have significant levels of repair
in vivo (typically 20 to 50% in groups C and
D), although the proteins are absolutely re-
quired in vitro. Of the seven-complementa-
tion groups, the A, B, D, and G forms mani-
fest neurological symptoms. A possible
explanation for the onset of neurological
abnormalities in XP patients is that defec-
tive DNA repair in nerve cells of endog-
enous (oxidative) NER lesions induces neu-
ronal death (Reardon et al., 1997).
Whereas the features of TTD have not
been found in combination with XP, muta-
tions in three of the XP genes, XP-B, XP-D,
and XP-G can give rise to combined symp-
toms of XP and CS (XP/CS). In addition to
these groups, there is a heterogeneous group
called XP variant (XP-V) in which cells
have normal excision repair but are defec-
tive in the so-called post-replication repair
(Boyer et al., 1990). These cells are only
slightly more sensitive than normal cells to
the killing action of UV light radiation
(Cordonnier and Fuchs, 1999). The spec-
trum of mutations is also different from that
in normal cells (Wang et al., 1993). The
clinical spectrum of this group is also vari-
able, ranging from severe cutaneous alter-
ations (including skin malignancies) to very
mildly affected individuals. In general, neu-
rological abnormalities have been observed
in only a few patients within this group. The
extracts from XP-V cells were also found to
be defective in translesion synthesis
(Cordonnier et al., 1999). There are some
specialized enzymes that can bypass DNA
damage and extend replication forks through
damaged sites. DNA polymerase ζ in the
yeast Saccharomyces cerevisiae is composed
of a catalytic subunit Rev3 (in the same
family as POL α, δ, and ε) and an accessory
factor Rev7, which together have the ability
to bypass pyrimidine dimers and other ad-
ducts in DNA (Lawrence and Hinkle, 1996;
Gibbs et al., 1998). The enzyme often in-
corporates incorrect nucleotides during by-
pass of damage. Another important human
DNA polymerase in this family is desig-
nated DNA polymerase η. This enzyme is
homologous to yeast Rad30 (Johnson et al.,
1999b) and consists of 713 amino acids.
POL η can bypass thymine-thymine dimers,
and usually two A residues are correctly
inserted opposite the lesion. Recently, it has
been shown that the XP-V cells lack this
particular bypass activity because of inacti-
vating mutations in the POL η gene (Johnson
et al., 1999a; Masutani et al., 1999a;
Masutani et al., 1999b). This explains pre-
vious observations of a defect in bypass of
damage in XP-V cells and cell extracts
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(Cordeiro-Stone et al., 1997; Svoboda et al.,
1998; Cordonnier et al., 1999) and accounts
for the marked hypermutability of XP-V
cells in response to UV light and some
chemical agents. POL η is missing in most
or all individuals with XP-V, indicating that
it is not essential for life. In XP-V cells,
NER can remove a large fraction of UV-
induced thymine-thymine dimers, but be-
cause pol η is missing, any remaining dimers
are more likely to be bypassed by poly-
merases such as pol ζ that incorporate in-
correct residues.
1. Genes Responsible for
Xeroderma Pigmentosum
Defects
XP-A gene codes for a protein that is
central to NER and binds to DNA, with a
preference for damaged DNA due to a vari-
ety of UV light and chemical damage (Wood,
1995). It also acts as an anchor for other
repair proteins to attach and carry out exci-
sion and replacement synthesis. The dam-
age recognition ability of XP-A is due to the
presence of a DNA-binding domain, which
combines a zinc finger, and a single-strand-
binding region, which may infiltrate small
single-stranded region, caused by helix-de-
stabilizing lesions. Mutations in XP-A that
are within the DNA binding site produce
more severe central nervous system disor-
ders, than mutations in the C-terminal re-
gion of the protein (Cleaver and States,
1997). On the other hand, mutations in two
members of the TFIIH complex, the XP-B
and XP-D genes are generally very severe
with both skin and central nervous system
disorders. Because these two genes act also
as helicases, they act in opening up the DNA
to initiate transcription as well. A deficiency
in one of these helicases can also produce
the symptoms of CS and in some cases,
TTD as well (Marionnet et al., 1995; Weeda
et al., 1997b). Because XP-D is part of the
TFIIH complex, it binds to the promoters of
the genes and facilitates the initiation of
transcription and is also involved in the re-
pair of damaged DNA. A number of muta-
tions have been found in XP-D when com-
pared with XP-B in which only a few
mutations have been detected (Taylor et al.,
1997; Sebastiaan Winkler and Hoeijmakers,
1998). Apparently, XP-D tolerates more mu-
tations, suggesting that its tertiary structure
is less critical for its activity in basal tran-
scription than that of XP-B. Each of the XP-
D mutation has a different effect on XP-D
activity and structure and most of the muta-
tions are clustered in the carboxy terminus
of the protein (Coin et al., 1998). The DNA
unwinding activities of the separate wild-
type XP-B and XP-D subunits with intact
TFIIH were compared. It was found that the
3′ to 5′ DNA helicase activity of XP-B is
weaker in the context of TFIIH than that of
the isolated protein, but the 5′ to 3′ unwind-
ing capacity of XP-D appeared to be more
potent when the protein is complexed with
the other TFIIH components. These data
suggest that some TFIIH subunits increase
the unwinding activity of XP-D. It has been
shown that the helicase activity of XP-D is
stimulated ~10-fold by its interaction with
the p44 subunit of TFIIH (Coin et al., 1998).
All of the C-terminal mutations of XP-D
result in the same biochemical defect: de-
creased helicase activity and concomitant
loss of detectable interaction with p44. An
inactivating deletion or truncating mutation
in XP-D is incompatible with the essential
transcription function of the protein (de Boer
and Hoeijmakers, 2000).
The moderate UV sensitivity and inter-
mediate repair synthesis typical of XP-F
patients could be due to the anticipated dual
function of the XP-F/ERCC1 complex in
NER and repair of interstrand crosslinks
(Davies et al., 1995). All XP-F cells exam-
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ined so far have a detectable, but greatly
reduced amount of XP-F protein (Yagi et
al., 1997). A null allele for XP-F or ERCC1
and the consequential defect in crosslink
repair may be incompatible with life.
A patient with the clinical features
of both xeroderma pigmentosum and
Cockayne’s syndrome has been reported
and this individual has unusual cellular re-
sponses to UV light. It has been shown that
the cultured fibroblasts and lymphocytes
of this patient are extremely sensitive to
irradiation with UV but the nucleotide ex-
cision repair is 30 to 40% that of the nor-
mal (Broughton et al., 1995). This particu-
lar deficiency has been assigned to the
XP-D complementation group and two
causative mutations in the XP-D gene have
been identified. The allele inherited from
the patient’s mother has a glycine to argi-
nine change at amino acid 675 and the
allele inherited from his father contains a –
1 frameshift at amino acid 669. Both these
mutations are present in the C-terminal 20%
of the 760 amino acid XP-D protein
(Broughton et al., 1995).
Two cases with the combined features
of XP and CS have been assigned to the XP-
D complementation group (Lafforet and
Dupuy, 1978; Broughton et al., 1995). It
was observed that despite their extreme UV
sensitivity, the cells from these patients
appeared to incise their DNA as efficiently
as normal cells. When irradiated plasmids
were introduced into nonirradiated XP-D/
CS cells, the ectopically introduced damage
triggered the induction of breaks in the un-
damaged genomic DNA (Berneburg et al.,
2000). XP-D/CS cells thus have a unique
response to sensing UV damage, which re-
sults in the introduction of breaks into the
DNA at sites distant from the damage. It has
been proposed that it is these spurious breaks
that are responsible for the extreme UV
sensitivity of these cells (Berneburg et al.,
2000).
B. Cockayne’s Syndrome
The major clinical features of Cockayne’s
syndrome (CS) are progressive leukodys-
trophy, dwarfism, progressive microceph-
aly, loss of adipose tissue, mental retarda-
tion, retinal atrophy, gait defects, cataracts,
dental caries, acute sun sensitivity and pro-
gressive growth retardation (Leech et al.,
1985; Lehmann, 1995). The majority of
patients present between the ages of 3 to 5,
often with sensorineural deafness, initially
masquerading as mild developmental delay,
but later including developmental delay.
Usually at this time, growth deficiency,
particularly with loss of adipose tissue, is
becoming apparent, as is a characteristic
facial appearance with sunken eyes. Neuro-
logical signs are mental retardation (intelli-
gence decline and behavior problems), loss
of gait and speech capacity, hyper-reflexia,
occasionally seizures and sensorineuronal
hearing loss (Otsuka and Robbins, 1985;
Cruz Martinez and Anciones, 1991). These
neurological features might be explained by
calcification of basal ganglia and more likely
by dysmyelination of the central and pe-
ripheral nervous system (Nance and Berry,
1992). The individuals affected with CS
display impaired sexual development and
postnatal growth failure and this condition
is termed cachectic dwarfism. The main
causes of death in these patients are pneu-
monia and respiratory infections and the
mean age of death is about 12 years (Nance
and Berry, 1992). Very rarely, individuals
have clinical features of both XP and CS.
XP complementation group G contains some
patients with the combined features of XP
and CS.
The NER occurs normally both in vivo
and in vitro in CS cells. The repair defect in
CS cells is manifested as retarded or absent
recovery of DNA (Lehmann et al., 1979) or
RNA synthesis (Mayne and Lehmann, 1982)
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after an UV challenge that normally recov-
ers within a few hours. Therefore, it is clear
now that CS cells are defective in an impor-
tant subpathway of NER. Following DNA
damage, it is very important for the cell to
remove damage from actively transcribed
regions of DNA, and in human cells repair
is more rapid in transcribed and in
untranscribed regions. Furthermore, it is the
transcribed strand that is repaired most rap-
idly and this preferential repair is referred to
as transcription-coupled repair. It seems that
transcription-coupled repair may in fact act
upstream of both nucleotide- and base-exci-
sion repair. The repair defect in CS was
shown to be based on an impaired preferen-
tial repair of the transcribed strand (Venema
et al., 1990; van Hoffen et al., 1993;).
1. Genes Defective in
Cockayne’s Syndrome
Complementation analysis has disclosed
three groups in CS: A, B, and C (Tanaka et
al., 1981; Lehmann, 1982). Groups A and B
comprise of the classical CS patients and
group C contains the patients with com-
bined XP and CS symptoms. A few CS
patients have also been assigned to the rare
XP groups B, D, or G. Two of the comple-
mentation groups of CS (CS-A and CS-B)
exhibit no defect in overall genomic NER,
but they are severely deficient in transcrip-
tion-coupled repair of certain lesions pro-
duced by ionizing radiation (Leadon and
Cooper, 1993). The involvement of CS genes
in transcription-coupled repair has led to
the suggestion that CS might also be a ‘tran-
scription syndrome’. Two candidates of tran-
scription-repair coupling factors are CS-A
and CS-B, respectively, encoded by the CS-
A and CS-B genes (Troelstra et al., 1992;
Henning et al., 1995). Mutations in either of
the two nonessential genes, CS-A or CS-B
result in defective transcription-coupled re-
pair and are the genetic defect in over 90%
of CS patients. The protein sequence of
CS-A contains the consensus of five “WD-
repeats” (Henning et al., 1995). This type of
motif is present in a number of proteins,
which are believed to possess a regulatory
rather than a catalytic role in many cellular
functions, including cell division, signal
transduction, messenger RNA modification,
and transcription (Neer et al., 1994). Many
of these WD-repeat proteins reside in
multiprotein complexes. The CS-A and XP-
G proteins interact with components of
TFIIH and CS-B interacts with CS-A and
XP-G (Henning et al., 1995). The product
of the CS-B gene contains a region of mul-
tiple ATPase/putative helicase motifs
(Troelstra et al., 1992; Guzder et al., 1996),
because it contains the seven conserved
domains which define a large superfamily
of DNA and RNA helicases (Gorbalenya
and Koonin, 1993). Extracts from CS-A and
CS-B cells show decreased levels of tran-
scription from the adenovirus major late
promoter in vitro and the defect is corrected
by transfection with the corresponding CS
gene (Chu and Mayne, 1996). Thus, although
the CS-A and CS-B genes are not essential
for transcription, mutations in these genes
might affect transcription indirectly. CS-B
knockout mice display only mild CS symp-
toms, but completely repair deficient CS-B/
XP-A double mutant mice suffer from se-
vere growth failure and die before weaning
(de Boer and Hoeijmakers, 1999).
It has been shown that DNA damage
produced by ionizing radiation (not ultra-
violet radiation) is subject to transcription-
coupled repair in normal human cells and in
XP-A mutant cells but not in CS-B mutant
cells (Leadon and Cooper, 1993). It might
be possible that all patients with CS are
deficient in the transcription-coupled repair
of different types of oxidative lesions. Oxi-
dative damage, including thymine glycols,
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is shown to be removed by transcription-
coupled repair in cells from normal indi-
viduals and from XP-A, XP-F and XP-G
patients who have NER defects but not from
XP-G patients who have severe CS. It seems
that transcription-coupled repair of oxida-
tive damage requires an XP-G function dis-
tinct from its NER endonuclease activity.
The XP-G gene in the three documented
cases of combined XP-G/CS has been ex-
amined. An unexpected common mutational
pattern in these three patients has been re-
ported suggesting an important second XP-
G function responsible for the CS clinical
phenotype (Nouspikel et al., 1997). These
three XP-G/CS patients had mutations that
would produce severely truncated XP-G
proteins. In contrast, two sibling XP-G pa-
tients without CS are able to make full-
length XP-G, but with a missense mutation
that inactivates its function in NER. These
results suggest that XP-G/CS mutations
abolish interactions required for a second
important XP-G function and that it is the
loss of this second function, that leads to the
CS clinical phenotype (Nouspikel et al.,
1997).
It has been shown that defective tran-
scription-coupled repair of oxidative damage
contributes to the developmental defects as-
sociated with CS (Cooper et al., 1997) and
XP-G is required for transcription-coupled
repair of such damage and probably this rep-
resents the second XP-G function. It has been
suggested that transcription-coupled repair
of oxidative damage is independent of the
XP-G incision function in NER, and even of
NER altogether. Instead, glycosylases and
AP endonucleases in a BER pathway pre-
sumably initiate this activity. This pathway
requires at least a transient interaction be-
tween XP-G and TFIIH, and perhaps other
proteins, to displace RNA polymerase II
stalled at a lesion (Donahue et al., 1994;
Habraken et al., 1996). Recently, transcrip-
tion-coupled repair of oxidative lesions has
been tested by Le Page et al. (2000). It has
been shown that CS cells, including CS-B,
XP-B/CS, XP-D/CS, and XP-G/CS not only
lack transcription-coupled repair but also
cannot remove 8-oxoG in a transcribed se-
quence, despite its proficient repair when not
transcribed. The XP-G/CS defect uniquely
slows lesion removal in nontranscribed se-
quences. This defective transcription-coupled
repair leads to a mutation frequency at
8-oxoG of 30 to 40% compared with the
normal 1 to 4%. The transcription by RNA
polymerase II is also blocked by unrepaired
8-oxoG. These data demonstrate that tran-
scription-coupled repair is required for poly-
merase release to allow repair and that CS
results from defects in transcription-coupled
repair of oxidative lesions (Le Page et al.,
2000). They also showed that 8-oxo-guanine
(or 8-oxo-guanine plus a ligand) is an ob-
stacle to the movement of RNA polymerase
II, and that the arrested polymerase must be
released to give the repair enzymes access to
the site. Therefore, not only is the transcrip-
tion-coupled repair is missing in CS, but the
blocked RNA polymerase II prevents lesion
recognition and repair by the global BER
pathway as well.
It has been proposed recently, that CS
could be characterized as a disease of exces-
sive cell death by apoptosis (Hanawalt, 2000).
This affects the rapidly metabolizing cells,
such as neurons, that generate high levels of
reactive oxygen species. This apoptosis model
could also explain the problems of stunted
growth and neurological deterioration. It
might also explain why CS patients are not
prone to skin cancer because dead cells do
not form tumors (Hanawalt, 2000).
C. Trichothiodystrophy
Trichothiodystrophy (TTD) is a rare, au-
tosomal recessive disorder characterized by
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sulfur-deficient brittle hair and nails, men-
tal retardation, impaired sexual development,
and ichthyosis (Itin and Pittelkow, 1990;
Tolmie et al., 1994). Scanning electron mi-
croscopy shows incomplete cuticles and
biochemical analysis shows that TTD hair
is severely deficient in cysteine-rich pro-
teins present in the cuticle cells. This has
led to the speculation that the brittle hair is
caused by decreased expression of genes
encoding the cysteine-rich proteins. TTD
hairs are dry and sparse, and the hair shaft
breaks easily. The specific reduction in cys-
teine-rich matrix protein expression in hair
of TTD patients indicates a defect in a late
stage of hair keratinocyte differentiation
(Gillespie and Marshall, 1983). Reduced
cysteine-rich matrix protein contents affect
the integrity of the hair shaft, because inter-
mediate keratin filaments are not crosslinked
properly. A similar defect may also explain
hypoplastic and easily breakable nails of
TTD patients (Itin and Pittelkow, 1990) as
well as the ichthyosis.
Photosensitivity has been reported in
approximately 50% of the cases, but no skin
cancer is associated with TTD. Virtually all
photosensitive TTD patients have a defi-
ciency in the NER of UV-induced DNA
damage that is indistinguishable from that
of xeroderma pigmentosum complementa-
tion group D patients. In addition to brittle
hair, these patients can have impaired intel-
ligence, decreased fertility and short stat-
ure. Those TTD patients with impaired in-
telligence appear to have neurological
deficits quite similar to CS, including ataxia,
spasticity and microcephaly. In a few cases,
calcification of the basal ganglia and
dysmyelination have been reported, which
could be the cause of clinical features (Chen
et al., 1994; Tolmie et al., 1994). Clinical
manifestations and their severity vary ex-
tensively between TTD individuals. It was
discovered that TTD is associated with de-
ficient NER (Yong et al., 1984).
1. Genes Responsible for
Trichothiodystrophy
The patients fall into three clinical
forms corresponding to mutations in three
genes. Complementation studies on about
20 UV-sensitive TTD families have shown
that the NER defect in all but two families
can be assigned to the XP-D complemen-
tation group (Stefanini et al., 1993a;
Stefanini et al., 1993b; Broughton et al.,
1994). The defect can also be assigned in
some families to the XP-B gene (Vermeulen
et al., 1994) and in a single individual to a
completely new nucleotide excision repair
gene designated TTD-A (Stefanini et al.,
1993b). Nucleotide-sequence analysis of
the XP-D cDNA from three TTD cell strains
(TTD1V1, TTD3VI, and TTD1RO) re-
vealed mutations within the region from
amino acid 713-730 and within previously
identified helicase functional domains
(Takayama et al., 1996). The various clini-
cal presentations and DNA repair charac-
teristics of the cell strains can be correlated
with the particular mutations found in the
ERCC2 locus. Mutations of Arg658 to ei-
ther His or Cys correlate with TTD cell
strains with intermediate UV-sensitivity,
mutations of Arg722 to Trp correlates with
highly UV-sensitive TTD cell strains, and
mutation of Arg 683 to Trp correlates with
XP-D. Alleles with mutation of Arg616 to
Pro or with the combined mutation of
Leu461 to Val and deletion of 716-730 are
found in both XP-D and TTD cell strains
(Takayama et al., 1996). Recovery of nor-
mal DNA repair and mutagenesis in
trichothiodystrophy cells after transduction
of the XP-D human gene has been reported
(Marionnet et al., 1996; Quilliet et al.,
1996). The causative mutation in two mild
TTD patients (TTD6VI and TTD4VI) was
assigned to XP-B gene. It was found to be
a single base substitution resulting in a
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missense mutation (T119P) in a region of
the XP-B protein completely conserved in
yeast, Drosophila, mouse, and man (Weeda
et al., 1997b).
A mouse model for the basal transcrip-
tion/DNA repair syndrome TTD has been
developed (de Boer et al., 1998a). The caus-
ative XP-D point mutation of a TTD patient
has been mimicked in the mouse. TTD mice
reflect to a remarkable extent the human
disorder, including brittle hair, developmen-
tal abnormalities, reduced life span, UV
sensitivity, and skin abnormalities. The cu-
taneous symptoms are associated with re-
duced transcription of a skin-specific gene
strongly supporting the concept of TTD as
a human disease due to inborn defects in
basal transcription and DNA repair (de Boer
et al., 1998a). It has also been reported that
in accordance with the cellular studies, TTD
mice exhibit a modestly increased sensitiv-
ity to UV-induced inflammation and hyper-
plasia of the skin. However, in striking con-
trast to the human syndrome, TTD mice
manifest a susceptibility to UV-and 7,12-
dimethylbenz(a)anthracene-induced skin
carcinogenesis, albeit not as pronounced as
the totally nucleotide excision repair-defi-
cient XP-A mice (de Boer et al., 1998b).
These findings suggest that TTD is associ-
ated with cancer predisposition and support
the notion that a NER deficiency enhances
cancer susceptibility (de Boer et al., 1999).
The unscheduled DNA synthesis of most
photosensitive TTD fibroblast lines is about
15 to 25% of the normal but in general TTD
fibroblasts are less sensitive to UV-induced
cell killing than XP-D cells. A subclass of
TTD fibroblasts with relatively high-unsched-
uled DNA synthesis (40 to 55%) and near
wild-type UV-survival exists. It has been
shown that photosensitive TTD cells have
defective cyclobutane pyrimidine dimers re-
pair but (partially) proficient repair of 6–4
photoproducts (Eveno et al., 1995). It was
also shown that cyclobutane pyrimidine
dimers are the predominant mutagenic le-
sions in TTD cells (Marionnet et al., 1998).
The UV-induced mutation spectra is differ-
ent between XP and TTD cells (Marionnet et
al., 1995). It was observed that although the
mutation frequency of the UV-irradiated pR2
vector was much higher in TTD and XP-D
cells than in normal cells, the mutation spec-
trum is closer between TTD and normal cells
when compared with XP-D cells (Madzak et
al., 1993; Marionnet et al., 1995). The cellu-
lar catalase activity is reduced in XP but not
TTD cells (Vuillaume et al., 1992). The TTD
repair defect differs from the XP-type XP-D
repair defect, which may explain to some
extent the absence of cancer development in
TTD patients. The postulated transcription
defect in TTD also might suppress the initia-
tion and/or progression of the carcinogenic
process.
VII. CONCLUSION AND FUTURE
PROSPECTS
The study of DNA repair occupies a
central place in modern biology. The field
of DNA repair in eukaryotes presently cov-
ers an enormous area and strong connec-
tions are being established between repair
and other areas, including DNA replication,
transcription, and cell-cycle controls, and
checkpoints. The crystallographic studies of
DNA repair enzymes are revealing a wide
range of structural motifs used to recognize
specific lesions in DNA. These studies will
also help to unravel the catalytic mecha-
nism by which these lesions are repaired.
The DNA repair disorders are clinically di-
verse. Most of the disorders cause growth
retardation and a predisposition to cancer
and some cause neurodegeneration and other
anomalies. Some disorder phenotypes may
be caused by mutations in more than one
gene. On the contrary, different mutations
Cr
iti
ca
l R
ev
ie
w
s i
n 
Bi
oc
he
m
ist
ry
 a
nd
 M
ol
ec
ul
ar
 B
io
lo
gy
 D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
11
7.
21
5.
12
9.
17
3 
on
 0
8/
01
/1
1
Fo
r p
er
so
na
l u
se
 o
nl
y.
280
in same gene can cause more than one dis-
ease phenotype. Further work is in progress
to determine how each gene causes a par-
ticular phenotype and what role they may
have in human development and disease.
The role of excision repair in diseases
other than XP, CS, and TTD still needs to
be established. It is important to study the
relationship between DNA damage, repair,
and aging in greater detail. It will be really
interesting to know whether malfunctioning
of excision repair causes aging and the vari-
ous ways to retard this unwanted aging pro-
cess.
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